You are viewing the public part of the archive. Login or request access to view more content.
Displaying 1-12 of 13 results
00:16:51
2008_84_05
XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.
2008_84_05
00:12:03
2008_83_05
XVII International AIDS Conference in Mexico City. Michelle Adato and Stuart Gillespie from the International Food Policy Research Institute (IFPRI) talk about how food security work can help decreasing poverty, prevent HIV and maintain the effect of ARV treatment.
2008_83_05
00:16:39
2008_82_02
XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.
2008_82_02
00:08:48
2008_79_03
XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.
2008_79_03
00:08:41
2008_78_03
XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.
2008_78_03
00:14:53
2003_11_01
Interview with Pathologist Christian Isichei, founder of the Faith Alive Hospital in Jos in Nigeria. He talks about the drug industry and access to ARV treatment in Africa and his experiences from the annual conference at the Institute of Human Virology (IHV) in Baltimore.
2003_11_01
00:08:56
2002_16
Gary Nabel, from the Vaccine Research Center (VRC) talks about engaging the scientific community and health personnel in HIV research and about the importance of international conferences to create these kinds of collaborations.
2002_16
00:07:02
2002_15
Marc Girard who is the general director of the Mérieux Foundation, talks about Cent Gardes and the collaboration between France and the USA, mainly represented by the Pasteur Institute and NIH, and about why HIV is such a complicated virus to find a vaccine for.
2002_15
00:24:33
2002_14
Dr Robert C Gallo talks about the importance of yearly AIDS congresses. He also talks about the scientific community before and during the AIDS epidemic, and puts the disease outbreak into a sociological context.
2002_14
00:16:11
2002_13
David Klatzmann is a french immunologist who has been working in an AIDS group in France since 1981. He talks about the discoveries that CD4-antigens function as receptors for the HIV virus and explains the structure of this relationship in detail.
2002_13
00:09:06
2002_12
Mary Marovich, medical scientist at The Walter Reed Army Medical Center in Washington, talks about the difficulties and possibilities of eventually finding an AIDS vaccine solution.
2002_12
00:17:37
2002_10
Luc Montagnier talks about the complex virology of HIV which makes the AIDS vaccine development so difficult. He also talks about the economic and cultural advantages of using traditional medicine as a part of the ARV therapy in developing countries.
2002_10











